Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
What is the Expected Growth Trajectory for the Irritable Bowel Syndrome (IBS) Treatment Market by 2033?
The market for treatment of irritable bowel syndrome (ibs) has seen a substantial expansion in the recent past. In terms of growth, it’s projected to surge from $2.5 billion in 2023 to $2.77 billion in 2024, recording a compound annual growth rate (CAGR) of 10.8%. The impressive growth in the previous period can be credited to an escalated prevalence of ibs, heightened awareness among patients, influences of stress and lifestyle, the existence of patient advocacy, support groups and beneficial healthcare reimbursement policies.
In the upcoming years, a swift rise is anticipated in the market size of irritable bowel syndrome (ibs) treatment, projecting it will escalate to $4.29 billion by 2028, with a compound annual growth rate (CAGR) of 11.6%. This progression during the predicted period can be traced back to the adoption of patient-centered health care models, the use of microbial treatments, the integration of blockchain technology in the medical sector, the implementation of patient-reported outcomes (pros), the introduction of accelerated regulatory programs, and the compatibility of health data. Key trends during this period include the incorporation of digital health solutions, advancements in diagnostic methodologies, boosted investment in research and development, initiatives for collaborations and partnerships, and the debut of non-pharmacological therapeutic procedures.
Claim Your Free Sample of the Global Irritable Bowel Syndrome (IBS) Treatment Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=11978&type=smp
What Factors Are Leading to Growth in the irritable bowel syndrome (ibs) treatment Market?
The escalation in cases of irritable bowel syndrome (IBS), a chronic gastrointestinal disorder, is anticipated to stimulate the expansion of the irritable bowel syndrome treatment market. The triggers behind the increased prevalence of IBS include unhealthy lifestyles, poor dietary choices, pollution exposure, and elevated stress. IBS treatments can diminish the intensity and recurrence of symptoms, enhance life quality, and empower individuals to better control their condition. The International Foundation for Gastrointestinal Disorders (IFFGD), a non-profit education and research organization based in the US, estimates that around 5–10% of the world’s population will have IBS by 2023, and between 25 and 45 million people in the United States will be affected. Consequently, the rising prevalence of IBS is a key factor propelling the growth of the IBS treatment market.
Which Segments Play a Key Role in Understanding the Irritable Bowel Syndrome (IBS) Treatment Market?
1) By Drug Type: Lubiprostone, Linaclotide, Eluxadoline, Rifaximin, Alosetron, Other Drugs
2) By Indication: IBS With Constipation, IBS With Diarrhea, IBS With Alternating Constipation And Diarrhea
3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
4) By End-Users: Hospitals, Clinics, Homecare Settings
What Trends Are Emerging as Game-Changers in the Irritable Bowel Syndrome (IBS) Treatment Market?
The recent surge in product innovations is a notable development in the irritable bowel syndrome (IBS) market. Leading entities within the industry are focusing on developing new and ground-breaking products to consolidate their market position. To exemplify, in April 2022, Ardelyx, a biotechnology firm based in the US, introduced IBSRELA, a pioneering IBS-C treatment for adults. Featuring as the solitary NHE3 inhibitor accessible for treating adult irritable bowel syndrome with constipation (IBS-C), it is Ardelyx’s first medicine to gain FDA approval. IBSRELA marks the first novel mechanism therapy to be created for IBS-C in nearly a decade. It significantly broadens the treatment possibilities for constipation, bloating, and stomach discomfort, which are symptoms associated with this debilitating condition.
Order Now for Fast Delivery of Your Irritable Bowel Syndrome (IBS) Treatment Market Report!
Which Regions Are Setting the Pace for Irritable Bowel Syndrome (IBS) Treatment Market Growth?
North America was the largest region in the irritable bowel syndrome (IBS) treatment market in 2023. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the irritable bowel syndrome (ibs) treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The Irritable Bowel Syndrome (IBS) Treatment Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the irritable bowel syndrome (ibs) treatment market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Irritable Bowel Syndrome (IBS) Treatment Market Include
1. Irritable Bowel Syndrome (IBS) Treatment Market Executive Summary
2. Irritable Bowel Syndrome (IBS) Treatment Market Segments
3. Irritable Bowel Syndrome (IBS) Treatment Market Size And Template Market Growth Rate
4. Key Irritable Bowel Syndrome (IBS) Treatment Market Trends
5. Major Irritable Bowel Syndrome (IBS) Treatment Market Drivers
……
25. Key Mergers And Acquisitions In The Irritable Bowel Syndrome (IBS) Treatment Market
26. Top Irritable Bowel Syndrome (IBS) Treatment Companies
27. Irritable Bowel Syndrome (IBS) Treatment Market Opportunities And Strategies
28. Irritable Bowel Syndrome (IBS) Treatment Market, Conclusions And Recommendations
29. Appendix
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
